index - Génétique et physiopathologie des MNM liées à la matrice extracellulaire et du noyau Accéder directement au contenu

Dernières publications

Chiffres clés

121 Publications avec texte intégral
1 Données de recherche

Open Access

47 %

Mots clés

Becker muscular dystrophy A-type lamin Rare neuromuscular diseases LGMD Allele-specific silencing Regeneration Adult SMA POPDC1 Lamin A/C nuclei Lamin A/C Gene therapy LMNA Myotubes Cardiology Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS COL6A1 C elegans Titin Angiotensin-converting enzyme inhibitor GNE Cardiomyopathy Laminopathies BVES Dystrophie musculaire Exome Allele-specific silencing therapy Butyrylcholinesterase Actionable gene COL1A1 Laminopathie BiP Emery-Dreifuss muscular dystrophy Muscle MRI Connective tissue Skeletal muscle Congenital muscular dystrophy AAV Myopathy Dilated cardiomyopathy Maladies rares A-type lamins Errance diagnostique C2C12 Dynamin 2 Angiotensin-converting enzyme inhibitors RNA interference Acetyltransferase Alternative splicing Clinical trial Dystrophine Emerin Biological sciences Muscular dystrophy INPP5K Nuclear envelope LMNA-related congenital muscular dystrophy Actionability Mouse CSF protein Laminopathy COL6A3 Collagen VI-related myopathies NGS collagen type VI congenital muscular dystrophy CMD limb-girdle muscular dystrophy LGMD muscular MRI neuromuscular disorders Lamin A/C LMNA gene Hypermobile EDS Myogenesis LMNA gene Treatment delay Heart failure Maladies rares et orphelines Biomarker Therapy Neuromuscular diseases Diagnosis Heart Centronuclear myopathy Myologie Cardiac conduction system Ehlers‐Danlos Syndrome Muscle Muscle biopsy Myopathies Rare diseases AAV VECTOR Autophagosome maturation Lamins Base de données FAIR Cancer Treatment Patient registry Next generation sequencing CMTX Muscular dystrophy MD IPSC Allele‐specific silencing therapy Duchenne muscular dystrophy CRISPR Cancer biomarkers Calcium handling Mutations COVID-19 Joint laxity